Biomerica Stock Today
| BMRA Stock | USD 0.71 0.01 0.97% |
Performance0 of 100
| Odds Of DistressLess than 33
|
Biomerica is trading at 0.713 as of the 24th of April 2024, a -0.97 percent decrease since the beginning of the trading day. The stock's open price was 0.72. Biomerica has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Biomerica are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of January 2005 | Category Healthcare | Classification Health Care |
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection andor treatment of medical conditions and diseases worldwide. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. The company has 16.82 M outstanding shares of which 66.5 K shares are currently shorted by private and institutional investors with about 1.55 trading days to cover. More on Biomerica
Moving together with Biomerica Stock
| 0.74 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
| 0.76 | NRC | National Research Corp | PairCorr |
Moving against Biomerica Stock
| 0.68 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
| 0.61 | NXL | Nexalin Technology | PairCorr |
| 0.48 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Biomerica Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biomerica's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomerica or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman, CEO and Pres | Zackary Irani | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Biomerica report their recommendations after researching Biomerica's financial statements, talking to executives and customers, or listening in on Biomerica's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Biomerica. The Biomerica consensus assessment is calculated by taking the average forecast from all of the analysts covering Biomerica. | |||||
Biomerica's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Biomerica's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biomerica's financial leverage. It provides some insight into what part of Biomerica's total assets is financed by creditors.
| |||||
Biomerica (BMRA) is traded on NASDAQ Exchange in USA. It is located in 17571 Von Karman Avenue, Irvine, CA, United States, 92614 and employs 62 people. Biomerica is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biomerica's market, we take the total number of its shares issued and multiply it by Biomerica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biomerica conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.82 M outstanding shares of which 66.5 K shares are currently shorted by private and institutional investors with about 1.55 trading days to cover.
Biomerica currently holds about 6.08 M in cash with (5.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45.
Check Biomerica Probability Of Bankruptcy
Ownership AllocationBiomerica retains a total of 16.82 Million outstanding shares. Biomerica shows 7.3 percent of its outstanding shares held by insiders and 26.72 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Biomerica Ownership Details
Biomerica Stock Price Odds Analysis
What are Biomerica's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Biomerica jumping above the current price in 90 days from now is over 95.22%. The Biomerica probability density function shows the probability of Biomerica stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Biomerica has a beta of 0.3322 suggesting as returns on the market go up, Biomerica average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Biomerica will be expected to be much smaller as well. Additionally, biomerica has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Biomerica to move above the current price in 90 days from now is over 95.22 (This Biomerica probability density function shows the probability of Biomerica Stock to fall within a particular range of prices over 90 days) .
Biomerica Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Biomerica that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Biomerica's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Biomerica's value.| Instituion | Recorded On | Shares | |
| Fore Capital, Llc | 2023-12-31 | 34.7 K | |
| Heritage Investors Management Corp | 2023-12-31 | 34.6 K | |
| Goss Wealth Management Llc | 2023-12-31 | 32.7 K | |
| Advisor Group Holdings, Inc. | 2023-12-31 | 21 K | |
| Penn Capital Management Company Llc | 2023-12-31 | 20.9 K | |
| Northern Trust Corp | 2023-12-31 | 20.8 K | |
| Lpl Financial Corp | 2023-12-31 | 15.2 K | |
| Two Sigma Securities, Llc | 2023-12-31 | 14.6 K | |
| Raymond James Finl Svs Advisors, Inc. | 2023-12-31 | 14.5 K | |
| Granahan Investment Management Inc.. | 2023-12-31 | 1.1 M | |
| Wasatch Advisors Inc. | 2023-12-31 | 953.3 K |
Biomerica Historical Income Statement
Biomerica Income Statement is one of the three primary financial statements used for reporting Biomerica's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Biomerica revenue and expense. Biomerica Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Biomerica's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 7.6 M, whereas Depreciation And Amortization is forecasted to decline to about 213.2 K. View More FundamentalsBiomerica Stock Against Markets
Picking the right benchmark for Biomerica stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biomerica stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biomerica is critical whether you are bullish or bearish towards Biomerica at a given time. Please also check how Biomerica's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biomerica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
| All Next | Launch Module |
Biomerica Corporate Directors
Biomerica corporate directors refer to members of a Biomerica board of directors. The board of directors generally takes responsibility for the Biomerica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biomerica's board members must vote for the resolution. The Biomerica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Francis Cano | Independent Director | Profile | |
| Jane Emerson | Independent Director | Profile | |
| Janet Moore | CFO, Treasurer, Secretary and Director | Profile | |
| MBA PharmD | Executive Director of Medical Affairs and Research and Sr. Advisor | Profile |
How to buy Biomerica Stock?
Before investing in Biomerica, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biomerica. To buy Biomerica stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biomerica. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biomerica stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biomerica stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biomerica stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biomerica, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Biomerica Stock please use our How to Invest in Biomerica guide.
Already Invested in Biomerica?
The danger of trading Biomerica is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biomerica is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biomerica. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biomerica is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.323 | Quarterly Revenue Growth (0.09) | Return On Assets (0.43) | Return On Equity (0.92) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.